Advertisement
Product › Details
Futura neotf single-use biomass sensor
Next higher product group | Futura biomass monitor (product series) | |
Status | 2021-03-22 sales start | |
Organisation | Aber Instruments Ltd. | |
Group | Aber Instruments (Group) | |
Aber Instruments. (3/22/21). "Press Release: Aber Introduces Futura neotf On-line Single-use Biomass Sensor". Aberystwyth.
For Accurate Process Fingerprinting of Cell Culture in Thermo Single-use Bioreactors
Aber Instruments (Aber), a world-leading manufacturer of on-line biomass monitoring technology, is delighted to announce its new Futura neotf single-use biomass sensor is available. The new sensor designed for easy integration with Thermo Scientific (Thermo) single-use bioreactors allows accurate process fingerprinting for on-line monitoring and control of cell culture, making it ideal for supporting seamless scale-up with biologics and vaccine manufacturing.
Based on Aber’s long-established, capacitance measurement technology, the Futura neotf single-use sensor can measure biomass on-line in a Thermo single-use bioreactor every 4 seconds. Unlike off-line biomass measurement approaches which are time-consuming and generate few data points, capacitance is sample-less and allows walk-away analysis, and collection of large amounts of real-time data without removing samples from the bioreactor. Process development runs can rapidly provide all the data to generate accurate fingerprints of a cell culture process to support Quality by Design (QbD).
Utilizing process fingerprints from Futura neotf, scientists can for example, maintain critical process parameters (CPPs) and critical quality attributes (CQAs) of their biologics and vaccines from batch to batch and can rapidly identify and prevent costly out of specification batches occurring. They can also use data from Futura neotf for advanced control such as determining optimum cell harvest or virus infection times, potentially improving product yield and quality, as well as reducing cost of goods. Consisting of a head amplifier and a single-use sensor, Futura neotf can easily be integrated via a proprietary port into Thermo single-use bioreactor ranges including the HyPerforma™. Developed with scalability in mind, the technology is compatible across sizes in bioreactors from 50 L to 2000 L, making it scalable through process development, clinical trials, and Current Good Manufacturing Practice (cGMP) cell culture production.
Futura neotf has been successfully tested internally by Thermo and externally by a major biopharmaceutical company to measure viable cell concentration (VCC) of Chinese hamster ovary (CHO) cells as part of its bioprocessing 4.0 workflow. The studies demonstrate that the single-use sensor was successful as a Process Analytical Technology (PAT) tool for measuring cell density in real-time with batch, fed-batch and perfusion applications.
John Poppleton, Director of Marketing and Sales at Aber Instruments explains: “Scientists tell us their off-line methods of measuring biomass not only risk contaminating the bioreactor but are time consuming and subjective. This means they only generate data points every 12-24 hours and measurements can vary by as much as 15 %. That’s why implementing on-line capacitance sensors and especially single-use ones is a key need for many process development scientists.”
Poppleton adds: “To meet this growing demand, we are pleased to be adding Futura neotf to our trusted biomass sensor range. The benefits for scientists working with Thermo single-use bioreactors are that they can now access our unrivalled technology to generate accurate process fingerprints to support QbD programmes and potentially drive down their biologics and vaccine manufacturing timelines.”
Due to the high level of interest anticipated following product release, Aber will prioritize supply of Futura neotf single-use on-line biomass sensors based on experience with the technology and its application. Wider access will come later in 2021 and scientists wanting to find out more about the new Futura neotf single-use on-line biomass sensor, should click this link: www.aberinstruments.com/futura-neo
Note to Editors
About Aber Instruments
Aber Instruments (Aber) founded in 1988, is a world-leading supplier of on-line biomass measurement for monitoring and control of cell culture. Aber’s long-established technology is based on a unique method for biomass measurement using cell capacitance developed and patented by Professor Douglas Kell and Dr Robert Todd from the University of Aberystwyth and the Centre for Alternative Technology.
Today, Aber is an employee owned company and its technology is used globally by thousands of companies across the biopharmaceutical, brewing, biorenewable, and biofuel industries. Its clients are among many of the world’s major biopharmaceutical and brewing firms and include Glaxo SmithKline, Novartis, AB InBev, Heineken, and SAB Miller.
Record changed: 2023-07-10 |
Advertisement
More documents for analytical instrument_other
- [1] Fida Biosystems ApS. (3/13/24). "Press Release: In-Solution Kinetics by Fida Biosystems – Redefining Drug Interaction Analysis for Therapeutic Discovery". Copenhagen....
- [2] Bruker Corporation. (10/4/23). "Press Release: Bruker Announces Majority Investment in MIRO Analytical AG, an Innovator in Compact, Highest-Precision QCL-Based Multi-Gas Analyzers (MGA)". Zürich....
- [3] Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin....
- [4] Dynamic Biosensors GmbH. (9/1/22). "Press Release: 2bind and Dynamic Biosensors Sign Technology-Service Partnership". Munich & Regensburg....
- [5] Creoptix AG. (1/11/22). "Press Release: Malvern Panalytical Expands Pharmaceutical Drug Development Solutions through the Acquisition of Creoptix"....
- [6] Eir Ventures Partners AB. (12/6/21). "Press Release: Eir Ventures Completes Investment in ArgusEye to Advance Innovative Sensor Technology for Real-time Monitoring of Bioproduction processes". Stockholm....
- [7] Creoptix AG. (1/12/21). "Press Release: Domainex Invests in the Creoptix WAVEdelta to Strengthen Its Fragment-based Drug Discovery Platform. Strong Partnership Ahead". Wädenswil & Saffron Walden....
- [8] Creoptix AG. (11/25/20). "Press Release: Creoptix and oneservice Partner for WAVEsystem After-sales Support". Wädenswil (Zurich)....
- [9] Axol Bioscience Ltd.. (10/13/20). "Press Release: Axol Bioscience Introduces Multi-electrode Array Screening Services for Human iPSC-derived Cells". Cambridge....
- [10] Creoptix AG. (12/10/19). "Press Release: Creoptix Appoints Line Stigen Raquet as Chief Executive Officer". Wädenswil (Zurich)....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top